HHS says the elimination of 22 mRNA vaccine development projects for COVID-19 and bird flu signals a shift in vaccine priorities.

The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.

The department is canceling 22 projects including awards to Moderna for bird flu vaccine development, contracts with Emory University and rejecting proposals from Pfizer and Sanofi.

The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.

Moderna MRNA announced that its seasonal influenza vaccine candidate, mRNA-1010, achieved superior relative vaccine efficacy (rVE) than an approved flu shot marketed by GSK plc GSK in a phase III ...

The department is canceling 22 projects including awards to Moderna for bird flu vaccine development, contracts with Emory University and rejecting proposals from Pfizer and Sanofi.

The vaccine’s efficacy was 26.6% higher than GSK’s flu shot in the overall study population that covered over 40,000 participants across 11 countries.